Wednesday, July 29, 2020

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir The drug, priced at 59 rupees (79 cents) per tablet, will be available at drug stores from Wednesday, privately held Hetero said.

from Moneycontrol Business News https://ift.tt/2Dfe7Pg

No comments:

Post a Comment

Madhu Kela picks up stake in this stock market proxy player in Q3

Veteran investor Madhu Kela has bought a stake in Emkay Global. This signals new interest in the financial services firm. Ace investor Dolly...